Trial Profile
A phase II, randomized, double-blind, two-dose, placebo-controlled multicentre study of 4-hydroxy tamoxifen [afimoxifene] gel for cyclical mastalgia in otherwise healthy pre-menopausal women with regular menstrual cycles
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Afimoxifene (Primary)
- Indications Breast pain
- Focus Therapeutic Use
- 02 Jun 2009 Results were presented at ASCO 2009.
- 14 Dec 2008 Results were reported at the 31st Annual San Antonio Breast Cancer Symposium.
- 01 Dec 2007 Results have been reported.